新型冠状病毒感染结核病后变化患者的主要肺活量指标
- 作者: Balasaniants G.S.1, Abdrakhmanova S.Z.2, Gilmutdinova L.T.3, Farkhshatov I.R.2
-
隶属关系:
- Kirov Military Medical Academy
- Sanatorium “Glukhovskaya”
- Bashkir State Medical University
- 期: 卷 26, 编号 4 (2024)
- 页面: 597-606
- 栏目: Original Study Article
- URL: https://ogarev-online.ru/1682-7392/article/view/285208
- DOI: https://doi.org/10.17816/brmma633454
- ID: 285208
如何引用文章
详细
对肺结核后残留变化患者在新型冠状病毒感染治愈后的主要肺活量参数进行研究。主要组研究对象为14例临床治愈的呼吸道结核病患者,从新型冠状病毒感染中康复出来,并在康复后于2020-2021年转入格鲁霍夫斯卡亚结核病疗养院接受治疗。对照组包括52例肺结核后残留变化患者,他们没有感染新型冠状病毒,且同年在疗养院接受了治疗。根据流行病学和临床标准,各组具有可比性,但结核病后遗症除外:主要组中有13例(92.9%)结核病后残留变化较小,1例(7.1%)结核病后残留变化较大,对照组中分别有36例(69.2%)和16例(30.8%)。外呼吸功能通过肺活量、用力肺活量、第一秒用力呼气量和第一秒强迫呼气量/强迫肺活量进行评估。 研究分别在患者入院时和入院1个月后进行。与对照组相比,主要治疗组在第一阶段的肺活量、用力肺活量和第一秒用力呼气量平均低于正常值(>80%)或更低,经过疗养治疗后,这些参数略有改善。对照组的初始指数明显更高,肺活量和用力肺活量的恢复速度与主要组相当,在第二次检查时,肺活量和用力肺活量的平均恢复水平接近,第一秒用力呼气量达到标准。最初,肺部通气能力的低指标与临床症状相关,因为主要组中 42.8%和对照组中55.7%的患者抱怨有呼吸困难。同时,在疗养治疗结束后,对照组患者的肺活量指数常低于60%:肺活量 — 病例的7.7%,用力肺活量 — 病例的17.3%,第一秒用力呼气量 — 病例的11.5%,而在主要组中,这些指数大多是轻度或中度下降。由此可见,新型冠状病毒感染会对呼吸系统的功能能力产生负面影响,而且结核病后的大量残留变化也会导致通气障碍的形成。
作者简介
Goar S. Balasaniants
Kirov Military Medical Academy
编辑信件的主要联系方式.
Email: vmeda-nio@mil.ru
ORCID iD: 0000-0001-6709-6789
SPIN 代码: 2288-9381
MD, Dr. Sci. (Medicine), professor
俄罗斯联邦, Saint PetersburgSumbul Z. Abdrakhmanova
Sanatorium “Glukhovskaya”
Email: sumbul.abdrahmanova@yandex.ru
ORCID iD: 0000-0001-7176-6554
SPIN 代码: 4499-6237
pulmonologist
俄罗斯联邦, Republic of BashkortostanLira T. Gilmutdinova
Bashkir State Medical University
Email: gilmutdinova23@mail.ru
ORCID iD: 0000-0003-3420-8400
SPIN 代码: 8940-5713
Ildus R. Farkhshatov
Sanatorium “Glukhovskaya”
Email: gluhovskaya@bk.ru
ORCID iD: 0000-0003-2837-6029
SPIN 代码: 5921-1360
phthisiologist
Republic of Bashkortostan参考
- van Kampen SC, Wanner A, Edwards M, et al. International research and guidelines on posttuberculosis chronic lung disorders: a systematic scoping review. BMJ Glob Health.2018;3(4):e000745. doi: 10.1136/bmjgh-2018-000745
- Schoeman I, Sifumba Z. Tuberculosis care does not end at treatment completion- a perspective from tuberculosis survivors. Lancet Infect Dis 2021;21(7):896–897. doi: 10.1016/S1473-3099(20)30941-5
- Harries AD, Lin Y, Thekkur P, et al. Why TB programmes should assess for comorbidities, determinants and disability at the start and end of TB treatment. Int J Tuberc Lung Dis. 2023;27(7):495–498. doi: 10.5588/ijtld.23.0178
- Allwood BW, van der Zalm MM, Amaral AFS, et al. Post-tuberculosis lung health: perspectives from the First International Symposium. Int J Tuberc Lung Dis, 2020;24(8):820–828. doi: 10.5588/ijtld.20.0067
- Allwood BW, Nightingale R, Agbota G, et al. Perspectives from the 2nd International Post-Tuberculosis Symposium: mobilising advocacy and research for improved outcomes. IJTLD OPEN. 2024;1(3):111–123. doi: 10.5588/ijtldopen.23.0619
- Migliori GB, Marx FM, Ambrosin N, et al. Clinical standards for the assessment, management and rehabilitation of post-TB lung disease. Int J Tuberc Lung Dis. 2021;25(10):797–813. doi: 10.5588/ijtld.21.0425
- Ots ON, Chushkin MI, Struchkov PV. Post-tuberculosis lung function impairment. Pulmonology. 2017;27(5):656–663. EDN: XNSQAH doi: 10.18093/0869-0189-2017-27-3-656-663
- Chernyak AV, Mustafina MKh, Naumenko ZhK, et al. Dynamics of functional in the respiratory system after covid-19-associated lung injury at one year after hospital discharge. Pulmonology. 2023;33(5):611–621. EDN: ITDWZT doi: 10.18093/0869-0189-2023-33-5-611-621
- Savushkina OI, Zaitsev AA, Kryukov EV, et al. Functional disorders of the respiratory system after a new coronavirus infection covid-19. Russian Military Medical Academy Reports. 2022;41(3):315–323. EDN: VWGNYU doi: 10.17816/rmmar108659
- Binegdie AB, Meme H, Sony AEl, et al. Chronic respiratory disease in adult outpatients in three African countries: a cross-sectional study. Int J Tuberc Lung Dis. 2022;26(1):18–25. doi: 10.5588/ijtld.21.0362
- Kryukov EV, Savushkina OI, Malashenko MM, et al. Influence of complex medical rehabilitation on pulmonary function and quality of life in patients after covid-19. Bulletin of Physiology and pathology of respiration. 2020;(78):84–91. EDN: KTYXEG doi: 10.36604/1998-5029-2020-78-84-91
- Adakun SA, Banda FM, Bloom A, et al. Disability, comorbidities and risk determinants at end of TB treatment in Kenya, Uganda, Zambia and Zimbabwe IJTLD OPEN. 2024;1(5):197–205. doi: 10.5588/ijtldopen.24.0082
- Kovlen DV, Abuseva GR, Khozyainova SS, et al. Rehabilitation of patients after a new coronavirus infection covid-19 at the second and third stage. Russian Military Medical Academy Reports. 2022;41(3):243–249. EDN: TYKTAQ doi: 10.17816/rmmar109250
- Mo X, Jian W, Su Z, et al. Abnormal pulmonary function in COVID-19 patients at time of hospital discharge. Eur Respir J. 2020;55(6):2001217. doi: 10.1183/13993003.01217-2020
补充文件
